eplerenone

(redirected from Inspra)
Also found in: Medical.
Related to Inspra: Altoprev

e·pler·e·none

 (əp-lĕr′ə-nōn′)
n.
A drug, C24H30O6, that blocks aldosterone receptors and is used to treat hypertension and congestive heart failure.

[ep(oxy) + perhaps (e)le(ven) (one of the positions to which the oxygen atom is attached to form the epoxide) + (t)r(i)enone, compound containing three double bonds and an attached oxygen.]
Translations

eplerenone

n eplerenona
References in periodicals archive ?
Business was offset by lower revenues in developed markets for Lyrica (GEP), Celebrex, Inspra and Viagra (GEP) as a result of the loss of exclusivity, as well as the performance of Lipitor and Norvasc in developed markets, and Zosyn/Tazocin in emerging markets, collectively down approximately $1.
A decision by the All Wales Medicines Strategy Group (AWMSG) means the drug eplerenone, also called inspra, can be used for adult patients with chronic heart failure after it examined research carried out by scientists in the USA and France.
In 2002, Pharmacia Pharmaceutics received FDA approval for Inspra (epleronone), a selective aldosterone receptor antagonist (Weber, 2001; Gad, 2005).
Pfizer is shifting the parcelling up of arthritis drugs Celebrex and Dynastat and heart treatment Inspra to other parts of its UK operation to ensure continuity once the Morpeth factory is sold.
Comment: Inspra blocks the binding of aldosterone, part of the renin-angiotensin-aldosterone system.
Sandoz has also announced the introduction of eplerenone tablets, a generic equivalent of Inspra.
One is Inspra, a selective aldosterone receptor antagonist that is approved for the treatment of hypertension and heart failure.
Pfizer's growth will be adversely affected by the continuing disappointing performance of recent launches Inspra and Caduet as well as the expiry of patents protecting Norvasc.